Literature DB >> 2144212

A molecular basis for familial hypertrophic cardiomyopathy: an alpha/beta cardiac myosin heavy chain hybrid gene.

G Tanigawa1, J A Jarcho, S Kass, S D Solomon, H P Vosberg, J G Seidman, C E Seidman.   

Abstract

An alpha/beta cardiac myosin heavy chain (MHC) hybrid gene is coinherited with familial hypertrophic cardiomyopathy (FHC) in one kindred. FHC is a disease of the heart muscle characterized by a thickening of the left ventricular wall with myocyte and myofibrillar disarray that is inherited as an autosomal dominant trait. We demonstrate here and in the accompanying article that the cardiac MHC genes, which encode integral myofibrillar components, are mutated in all affected individuals from two unrelated families with FHC. In one kindred, an unequal crossover event during meiosis may have produced the alpha/beta cardiac MHC hybrid gene that is present in affected individuals. We conclude that mutations in the cardiac MHC genes can cause FHC.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144212     DOI: 10.1016/0092-8674(90)90273-h

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  62 in total

1.  Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies.

Authors:  Kenneth R Chien
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

2.  HLA gene analysis in a Japanese family with hypertrophic cardiomyopathy by restriction fragment length polymorphism.

Authors:  T Kanda; N Takeuchi; A Hasegawa; T Suzuki; K Murata
Journal:  Heart Vessels       Date:  1992       Impact factor: 2.037

3.  No evidence for linkage of familial hypertrophic cardiomyopathy and chromosome 14q1 locus D14S26 in a Chinese family: evidence for genetic heterogeneity.

Authors:  Y L Ko; W P Lien; J J Chen; C W Wu; T K Tang; C C Liew
Journal:  Hum Genet       Date:  1992-08       Impact factor: 4.132

Review 4.  The genetic basis of hypertrophic cardiomyopathy in cats and humans.

Authors:  Mark D Kittleson; Kathryn M Meurs; Samantha P Harris
Journal:  J Vet Cardiol       Date:  2015-12       Impact factor: 1.701

5.  Expression of a missense mutation in the messenger RNA for beta-myosin heavy chain in myocardial tissue in hypertrophic cardiomyopathy.

Authors:  M B Perryman; Q T Yu; A J Marian; A Mares; G Czernuszewicz; J Ifegwu; R Hill; R Roberts
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

Review 6.  Problems in diagnosis and management of hypertrophic cardiomyopathy.

Authors:  O Odemuyiwa; W J McKenna
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

Review 7.  Progress in familial hypertrophic cardiomyopathy: molecular genetic analyses in the original family studied by Teare.

Authors:  H Watkins; C E Seidman; C MacRae; J G Seidman; W McKenna
Journal:  Br Heart J       Date:  1992-01

8.  The genetics of hypertrophic cardiomyopathy.

Authors:  D M Gilligan; J G Cleland; C M Oakley
Journal:  Br Heart J       Date:  1991-09

9.  Functional analysis of myosin missense mutations in familial hypertrophic cardiomyopathy.

Authors:  A J Straceski; A Geisterfer-Lowrance; C E Seidman; J G Seidman; L A Leinwand
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

10.  Long-term course and cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy.

Authors:  M Shimizu; N Sugihara; Y Kita; K Shimizu; Y Horita; K Nakajima; J Taki; R Takeda
Journal:  Br Heart J       Date:  1992-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.